Manoj K. Aswar

Pune, MH 411033, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Development and Evaluation of Intranasal Nanostructured Lipid Carriers Encapsulating Donepezil HCl and Caesalpinia bonduc Seed Extract for Targeting Alzheimer's Disease: in vitro and in vivo evaluation.

Development and Evaluation of Intranasal Nanostructured Lipid Carriers Encapsulating Donepezil HCl and Caesalpinia bonduc Seed Extract for Targeting Alzheimer's Disease: in vitro and in vivo evaluation.

Journal: Journal of drug targeting

Published: May 11, 2026

Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential.

Mitochondria-Targeted Nanotherapies in Aging Neurodegenerative Disorders: Emerging Prospects and Clinical Potential.

Journal: Advanced healthcare materials

Published: May 10, 2026

Stigmasterol Alleviates Levodopa-Induced Dyskinesia in 6-OHDA-Induced Parkinsonian Rats.

Stigmasterol Alleviates Levodopa-Induced Dyskinesia in 6-OHDA-Induced Parkinsonian Rats.

Journal: Neurochemical research

Published: June 17, 2025

Fluoxetine HCl-Loaded Nanostructured Lipid Carriers for Nose-to-Brain Delivery: Optimization and Synergistic Role of Saffron Oil.

Fluoxetine HCl-Loaded Nanostructured Lipid Carriers for Nose-to-Brain Delivery: Optimization and Synergistic Role of Saffron Oil.

Journal: Journal of molecular neuroscience : MN

Published: June 12, 2025

Behavioral and Proteomic Studies Reveal Methylglyoxal Activate Pathways Associated with Alzheimer's Disease.

Behavioral and Proteomic Studies Reveal Methylglyoxal Activate Pathways Associated with Alzheimer's Disease.

Journal: ACS pharmacology & translational science

Published: July 17, 2022

Buspirone, a 5-HT1A agonist attenuates social isolation-induced behavior deficits in rats: a comparative study with fluoxetine.

Buspirone, a 5-HT1A agonist attenuates social isolation-induced behavior deficits in rats: a comparative study with fluoxetine.

Journal: Behavioural pharmacology

Published: April 19, 2022

Self-microemulsifying drug delivery system (SMEDDS) of curcumin attenuates depression in olfactory bulbectomized rats.

Self-microemulsifying drug delivery system (SMEDDS) of curcumin attenuates depression in olfactory bulbectomized rats.

Journal: Heliyon

Published: April 08, 2019

Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats.

Ferulic acid ameliorates doxorubicin-induced cardiac toxicity in rats.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: August 28, 2018

Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice.

Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice.

Journal: Journal of psychopharmacology (Oxford, England)

Published: December 08, 2017

Telmisartan attenuates diabetes induced depression in rats.

Telmisartan attenuates diabetes induced depression in rats.

Journal: Pharmacological reports : PR

Published: September 08, 2016

Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response.

Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response.

Journal: Physiology & behavior

Published: August 26, 2016

Ferulic acid ameliorates chronic constriction injury induced painful neuropathy in rats.

Ferulic acid ameliorates chronic constriction injury induced painful neuropathy in rats.

Journal: Inflammopharmacology

Published: May 12, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026